Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity
Jennifer L. Leddon(University of Cincinnati), Timothy P. Cripe(Nationwide Children's Hospital), Timothy D. Eubank(West Virginia University), William F. Goins(University of Pittsburgh), Amy C. Gross(The Ohio State University), Mark A. Currier(Nationwide Children's Hospital), Joseph C. Glorioso(University of Pittsburgh), Kellie B. Haworth(Nationwide Children's Hospital), David A. Hildeman(University of Cincinnati Medical Center), Pin-Yi Wang(Nationwide Children's Hospital), Michael Arnold(Children's Hospital Colorado), Francesca Jung(Nationwide Children's Hospital), Justus B. Cohen(University of Pittsburgh), Nicholas Denton(Nationwide Children's Hospital), Chun‐Yu Chen(Guangdong Pharmaceutical University), Paola Grandi(University of Pittsburgh), Kevin M Cripe(Nationwide Children's Hospital)
Cited by 44
Related Papers
The immune cell landscape in kidneys of patients with lupus nephritis
|Nature Immunology|2019|840
MEF2C Transcription Factor Controls Chondrocyte Hypertrophy and Bone Development
|Developmental Cell|2007|457
Mre11 Nuclease Activity Has Essential Roles in DNA Repair and Genomic Stability Distinct from ATM Activation
|Cell|2008|341
Covalently Linked Au Nanoparticles to a Viral Vector: Potential for Combined Photothermal and Gene Cancer Therapy
|Nano Letters|2006|260
Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis
|The Journal of Experimental Medicine|2007|223